Peer Reviewed

Molecular Chaperones Shown to Assist in the Fight against Huntington Disease

Huntington’s disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put a stop to the insidious disintegration of brain cells. Fortunately, scientists discovered a natural mechanism, which not only suppresses the build-up of pathogenic amyloid fibrils but also disaggregates them. The scientists declared that the newly discovered molecular chaperones may soon be crucial parts of new therapeutic approaches.

In the past, Huntington’s disease was also called Saint Vitus’ Chorea (chorea = dance). As of today, Huntington’s disease, like the neurodegenerative diseases named after Alzheimer and Parkinson, is incurable. A mutation in the dominant Huntingtin (Htt) gene causes Huntington’s disease. This distinguishes Huntington’s disease from Alzheimer and Parkinson. The Htt mutation involves a DNA segment with extra repeats of the polyglutamine-coding CAG triplet. The greater the number of extra repeats there are of this polyglutamine-coding segment, the more prone is the Huntingtin protein to improper folding and aggregation into pathogenic amyloid fibrils. In the affected cells and brain regions, the long fibrous proteins keep accumulating. The protein aggregates interfere with many physiological functions. Finally, the disease process will lead to cell degeneration and cell death.

Image courtesy: Annika Scior, FMP

So far, there is no therapy for patients with Huntington’s disease. In a new approach, scientists focus on reducing the amyloid plaque formation due to the presence of the Htt protein. So far, scientists still did not succeed in the complete suppression of the pathogenic process. It was also unclear whether the fibrils can be disaggregated once they have formed.

Still, suppression and reversal of the Htt-fibril formation are obviously feasible. For the first time, scientists at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin in collaboration with their peers working at the Max Delbrück Center for Molecular Medicine (MDC) and at the Charité University Hospital discovered a natural mechanism, which prevents the accumulation of pathogenic amyloid fibrils completely and can disaggregate already existing plaques inside the cells. A complex of three molecular chaperones is involved. Chaperones are proteins with abilities to help other proteins to mature, to avoid improper contacts and to correct errors.

READ  Wildcats mimic their prey’s calls to hunt them

Dr. Janine Kirstein (FMP) reports: “We were able to show that the trimeric chaperone complex of Hsc70, DNAJB1, and Apg2 is able to suppress the Htt-fibril formation entirely! The same chaperone complex is also able to disaggregate the Htt fibrils. This plaque removal opens new venues for therapeutic approaches.”

An innovative fluorescence-based Htt-fibril formation assay developed in the laboratory of Erich Wanker (MDC) enabled the scientists to test the impact of individual chaperones and chaperone complexes on the Htt-protein aggregation and helped to identify the key players. Moreover, the scientists also succeeded in demonstrating the relevance of the identified chaperones in induced pluripotent stem cells (iPSCs) obtained from patients suffering from Huntington’s disease. Clinician Josef Priller (Charité) and Alessandro Prigione (group leader at the MDC) played significant roles in this part of the project. Yet another insight emerged from the joint investigations. The over-expression of the DNAJB1 chaperone (probably the limiting factor) of the three-chaperone complex results in a significant reduction of the Htt aggregation in cell cultures.

It is quite possible that chaperones play a role not only in Huntington’s disease but also in other neurodegenerative diseases. Therefore, the scientists will extend their research also to other amyloid proteins such as Amyloid beta and tau in Alzheimer Disease or TDP-43 in cases of ALS.”

Reference:

Annika Scior, Alexander Buntru, Kristin Arnsburg, Anne Ast, Manuel Iburg, Katrin Juenemann, Maria Lucia Pigazzini1, Barbara Mlody, Dmytro Puchkov, Josef Priller, Erich E. Wanker, Alessandro Prigione & Janine Kirstein, Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex, im Druck in EMBO Journal, doi: 10.15252/embj.201797212

more recommended stories